Current concepts - Positron-emission tomography and assessment of cancer therapy

被引:547
作者
Juweid, ME
Cheson, BD
机构
[1] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA
[2] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[3] Georgetown Univ Hosp, Div Hematol Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
D O I
10.1056/NEJMra050276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Positron-emission tomography (PET) has become an important tool for evaluating tumors, detecting occult cancer, and staging and restaging tumors. This review includes a Web-only supplement with scans from 10 patients with common cancers. Copyright © 2006 Massachusetts Medical Society.
引用
收藏
页码:496 / 507
页数:12
相关论文
共 59 条
  • [1] Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients
    Ahmad, A
    Barrington, S
    Maisey, M
    Rubens, RD
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 478 - 482
  • [2] Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
    Allen-Auerbach, M
    Quon, A
    Weber, WA
    Obrzut, S
    Crawford, T
    Silverman, DHS
    Ratib, O
    Phelps, ME
    Czernin, J
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (06) : 411 - 416
  • [3] Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET
    Antoch, G
    Saoudi, N
    Kuehl, H
    Dahmen, G
    Mueller, SP
    Beyer, T
    Bockisch, A
    Debatin, JF
    Freudenberg, LS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4357 - 4368
  • [4] Arulampalam T H, 2001, Lancet Oncol, V2, P172, DOI 10.1016/S1470-2045(00)00259-X
  • [5] Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer
    Bender, H
    Bangard, N
    Metten, N
    Bangard, M
    Mezger, J
    Schomburg, A
    Biersack, HJ
    [J]. HYBRIDOMA, 1999, 18 (01): : 87 - 91
  • [6] The cost of positron emission tomography in six United States Veterans Affairs Hospitals and two Academic Medical Centers
    Berger, M
    Gould, MK
    Barnett, PG
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (02) : 359 - 365
  • [7] Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography
    Bos, R
    van der Hoeven, JJM
    van der Wall, E
    van der Groep, P
    van Diest, PJ
    Comans, EFI
    Joshi, U
    Semenza, GL
    Hoekstra, OS
    Lammertsma, AA
    Molthoff, CFM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 379 - 387
  • [8] FDG pet studies during treatment:: Prediction of therapy outcome in head and neck squamous cell carcinoma
    Brun, E
    Kjellén, E
    Tennvall, J
    Ohlsson, T
    Sandell, A
    Perfekt, R
    Wennerberg, J
    Strand, SE
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (02): : 127 - 135
  • [9] Bury T, 1999, EUR RESPIR J, V14, P1376
  • [10] RESIDUAL MASS IN LYMPHOMA MAY NOT BE RESIDUAL DISEASE
    CANELLOS, GP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) : 931 - 933